CN102512652B - Medicinal composition for treating peptic ulcer - Google Patents
Medicinal composition for treating peptic ulcer Download PDFInfo
- Publication number
- CN102512652B CN102512652B CN 201210005612 CN201210005612A CN102512652B CN 102512652 B CN102512652 B CN 102512652B CN 201210005612 CN201210005612 CN 201210005612 CN 201210005612 A CN201210005612 A CN 201210005612A CN 102512652 B CN102512652 B CN 102512652B
- Authority
- CN
- China
- Prior art keywords
- parts
- peptic ulcer
- rhizoma
- medicinal composition
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000008469 Peptic Ulcer Diseases 0.000 title claims abstract description 14
- 208000011906 peptic ulcer disease Diseases 0.000 title claims abstract description 14
- 239000000203 mixture Substances 0.000 title abstract description 5
- 239000003814 drug Substances 0.000 claims abstract description 14
- 241000218176 Corydalis Species 0.000 claims abstract description 6
- 229940079593 drug Drugs 0.000 claims abstract description 6
- 241001522129 Pinellia Species 0.000 claims abstract description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 9
- 241000903946 Clematidis Species 0.000 claims description 5
- 241000628997 Flos Species 0.000 claims description 5
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 7
- 238000002360 preparation method Methods 0.000 abstract description 7
- 206010067482 No adverse event Diseases 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 241000218158 Clematis Species 0.000 abstract 1
- 241000132446 Inula Species 0.000 abstract 1
- 240000002948 Ophiopogon intermedius Species 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 229940046011 buccal tablet Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007919 dispersible tablet Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 238000002575 gastroscopy Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 229940023488 pill Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Te invention relates to a medicinal composition for treating peptic ulcer. The medicinal composition is a preparation which is prepared from the following raw material medicines in parts by weight: 1-10 parts of dwarf lilyturf root, 1-10 parts of inula flower, 1-5 parts of rhubarb, 1-5 parts of pinellia tuber, 1-5 parts of ginger, 1-5 parts of tuckahoe, 1-20 parts of clematis root, 1-10 parts of corydalis tuber and 1-10 parts of gallnut. The medicinal composition provided by the invention has a rational prescription and a clear curative effect, can be used for effectively treating the peptic ulcer and has the advantages of preventing and treating the effect of the peptic ulcer, along with no adverse reaction and low price.
Description
Technical field
The present invention relates to field of medicaments, specifically, relate to a kind of pharmaceutical composition for the treatment of peptic ulcer.
Background technology
Adopt clinically H
2The short term effect of receptor antagonist treatment peptic ulcer gains public acceptance, but owing to can not continue to take medicine to the serious order of hepatic and renal function injure, therefore still have the patient about 20% need change his method treatment, the little medicine of side effect seems very necessary so select good effect clinically.
Summary of the invention
The purpose of this invention is to provide a kind of pharmaceutical composition for the treatment of peptic ulcer.
In order to realize purpose of the present invention, the invention provides a kind of pharmaceutical composition for the treatment of peptic ulcer, it is the medicament of being made by weight by following bulk drugs: 1～10 part of 1～10 part of Radix Ophiopogonis, 1～10 part of Flos Inulae, 1～5 part of Radix Et Rhizoma Rhei, 1～5 part of the Rhizoma Pinelliae, 1～5 part in Rhizoma Zingiberis Recens, 1～5 part in Poria, 1～20 part of Radix Clematidis, 1～10 part of Rhizoma Corydalis and Galla Chinensis.
Preferably, it is the medicament of being made by weight by following bulk drugs: 6 parts of 5 parts of Radix Ophiopogonis, 5 parts of Flos Inulae, 3 parts of Radix Et Rhizoma Rhei, 3 parts of the Rhizoma Pinelliaes, 2 parts in Rhizoma Zingiberis Recens, 2 parts in Poria, 15 parts of Radix Clematidis, 6 parts of Rhizoma Corydalis and Galla Chinensiss.
Pharmaceutical composition of the present invention can be made various dosage forms with pharmaceutically acceptable carrier, such as tablet, dispersible tablet, buccal tablet, capsule, pill, granule, powder or decoction etc.Can adopt preparation technique means well known in the art to finish the preparation of pharmaceutical composition of the present invention.
Described pharmaceutically acceptable carrier is well known, is usual excipients or the adjuvant for the preparation of above-mentioned preparation.Excipient or adjuvant commonly used comprise (but being not limited to) filler, lubricant, dispersant, wetting agent, binding agent, antioxidant etc., for example, syrup, arabic gum, sorbitol, lactose, dextrin, starch, calcium carbonate, Pulvis Talci, Polyethylene Glycol, carboxymethyl starch sodium, magnesium stearate etc.
The reasonable recipe of pharmaceutical composition of the present invention, curative effect is clear and definite, can effectively treat peptic ulcer, have the prevention and the treatment peptic ulcer effect, have no adverse reaction, low-cost advantage.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 medicinal composition tablets of the present invention
Take by weighing gram Radix Ophiopogonis 50, Flos Inulae 50 grams, Radix Et Rhizoma Rhei 30 grams, the Rhizoma Pinelliae 30 grams, Rhizoma Zingiberis Recens 20 grams, Poria 20 grams, Radix Clematidis 150 grams, Rhizoma Corydalis 60 grams and Galla Chinensis 60 grams, chopping, the water of 12 times of crude drug weight of adding, 100 ℃ of heating decocted 3 hours, filter, collect filtrate.It is 1.4 (50 ℃) thick paste that filtrate is concentrated into relative density, and drying is pulverized, add microcrystalline Cellulose 150 grams, mannitol 60 grams, carboxymethyl starch sodium 20 grams, mixing adds the amidin soft material processed of 8% (w/w), granulate, make 200 in tablet.
Experimental example
Diagnostic criteria:
All cases are all diagnosed about the diagnostic criteria of peptic ulcer with reference to the higher medical institution teaching material " internal medicine " of People's Health Publisher's publication in 1996.Its clinical manifestation has that the upper abdomen stomach headquarters or seat of leading organs of an institute like the Chinese Academy of Sciences is painful to be disclosed, nausea and vomiting, and heating installation pantothenic acid, inappetence, abdominal distention etc., the visible activeness ulcer of gastroscopy focus exists, and checks the epigastrium pain that the pathological changes of internal organs such as getting rid of livers, gallbladder, pancreas causes through other.
Close case 50 examples of the standard of stating of selector, male's 25 examples wherein, 38.7 years old mean age, women's 25 examples, 34.2 years old mean age.
Therapeutic scheme
Use the tablet of preparation among the embodiment 1 to treat, one day three times, each two, treating continuously seven days is a course for the treatment of.
Efficacy assessment standard
The criterion of therapeutical effect of " the clinical common disease diagnosis and treatment standard " of publishing with reference to Beijing Medical University in 1993, combined publication society of China Concord Medical Science University is drafted.Cure: sings and symptoms disappears, and gastroscope check ulcer healing enters cicatricial phase; Take a turn for the better: sings and symptoms obviously alleviates or substantially disappears, and gastroscope check ulcer is dwindled more than 1/2 the attenuation of tongue film; Invalid: sings and symptoms is without improvement, and gastroscope check ulcer is not dwindled or is front enlarger.
Therapeutic outcome:
Through the treatment of a course for the treatment of, whole 50 routine patients all meet the standard of healing.
Untoward reaction
In therapeutic process, do not find obvious untoward reaction.
Claims (2)
1. pharmaceutical composition for the treatment of peptic ulcer, it is characterized in that it is the medicament of being made by weight by following bulk drugs: 1～10 part of 1～10 part of Radix Ophiopogonis, 1～10 part of Flos Inulae, 1～5 part of Radix Et Rhizoma Rhei, 1～5 part of the Rhizoma Pinelliae, 1～5 part in Rhizoma Zingiberis Recens, 1～5 part in Poria, 1～20 part of Radix Clematidis, 1～10 part of Rhizoma Corydalis and Galla Chinensis.
2. the pharmaceutical composition for the treatment of peptic ulcer according to claim 1, it is characterized in that it is the medicament of being made by weight by following bulk drugs: 6 parts of 5 parts of Radix Ophiopogonis, 5 parts of Flos Inulae, 3 parts of Radix Et Rhizoma Rhei, 3 parts of the Rhizoma Pinelliaes, 2 parts in Rhizoma Zingiberis Recens, 2 parts in Poria, 15 parts of Radix Clematidis, 6 parts of Rhizoma Corydalis and Galla Chinensiss.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210005612 CN102512652B (en) | 2012-01-10 | 2012-01-10 | Medicinal composition for treating peptic ulcer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210005612 CN102512652B (en) | 2012-01-10 | 2012-01-10 | Medicinal composition for treating peptic ulcer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102512652A CN102512652A (en) | 2012-06-27 |
| CN102512652B true CN102512652B (en) | 2013-03-13 |
Family
ID=46283904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210005612 Expired - Fee Related CN102512652B (en) | 2012-01-10 | 2012-01-10 | Medicinal composition for treating peptic ulcer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102512652B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105617085A (en) * | 2015-12-23 | 2016-06-01 | 高长忠 | Composition for treating peptic ulcer and preparation method thereof |
-
2012
- 2012-01-10 CN CN 201210005612 patent/CN102512652B/en not_active Expired - Fee Related
Non-Patent Citations (4)
| Title |
|---|
| 中医药治疗消化性溃疡研究近况;贺俭;《中医药信息》;19981231(第4期);14-16 * |
| 吴连恩等.自拟合欢愈疡汤治疗消化性溃疡108例.《河北中医》.1999,第21卷(第5期),271-272. |
| 自拟合欢愈疡汤治疗消化性溃疡108例;吴连恩等;《河北中医》;19990930;第21卷(第5期);270-271 * |
| 贺俭.中医药治疗消化性溃疡研究近况.《中医药信息》.1998,(第4期),14-16. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102512652A (en) | 2012-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103356956A (en) | Traditional Chinese medicine composition for treating autoimmune liver disease and preparation method thereof | |
| CN102579788B (en) | Medicinal composition for treating peptic ulcer | |
| CN102512652B (en) | Medicinal composition for treating peptic ulcer | |
| CN102657828A (en) | Pharmaceutical composition for treating chronic heart failure | |
| CN103394002B (en) | Medicinal composition for treating cutaneous pruritus as well as preparation method and application thereof | |
| CN102895574B (en) | Medicament for treating acute gastritis | |
| CN102488801B (en) | Medicine composition for curing chronic gastritis | |
| CN101450195A (en) | Traditional Chinese medicine composition for treating stomach cold | |
| CN103948899B (en) | A kind of Tibetan medicine for the treatment of atrophic gastritis | |
| CN102091138B (en) | Gastrointestinal tablet and preparation process thereof | |
| CN102274428B (en) | Pharmaceutical composition with effect on treating irritable bowel syndrome and preparation method and application thereof | |
| CN101548990B (en) | Powder pharmaceutical formulations for treating infantile diarrhea | |
| CN101607061A (en) | A kind of drug regimen of protecting gastric mucosa and preparation method thereof | |
| CN102670819B (en) | Medicine composition for treating cold | |
| CN102362879B (en) | Traditional Chinese herbal medicinal preparation for relieving ulcer by inhibiting gastric acid and preparation method thereof | |
| CN102886011A (en) | Traditional Chinese medicine for treating dyspepsia | |
| CN1220508C (en) | Medicine for curing diseases of digestive system and its preparation method | |
| CN101670046A (en) | Chinese medicinal composition for gastritis and esophagitis and preparation process thereof | |
| CN102205086A (en) | Chinese medicinal composition for treating gastric and duodenal ulcer and preparation method thereof | |
| CN101579495B (en) | Application of Chinese medicine composite in preparation of medicine for treating chronic gastritis | |
| CN102205087B (en) | Chinese medicinal composition for treating chronic gastritis and preparation method thereof | |
| CN105213780A (en) | A kind of Chinese medicine composition and application thereof for the treatment of chronic gastritis | |
| CN104001077A (en) | Traditional Chinese medicine composition for treating urinary tract infection and application thereof | |
| CN103948900B (en) | A kind of preparation method for the treatment of atrophic gastritis Tibetan medicine | |
| CN104055886A (en) | Medicinal composition for treating chronic cough, and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: TIANJIANG PHARMACEUTICAL INDUSTRY CO., LTD., JIANG Free format text: FORMER OWNER: SONG XUEPING Effective date: 20130809 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 272100 JINING, SHANDONG PROVINCE TO: 214400 WUXI, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130809 Address after: 214400 Jiangyin Economic Development Zone, Jiangsu, Qin Shan Road, No. 8 Patentee after: Tianjiang Pharmaceutical Industry Co., Ltd., Jiangyin Address before: 272100 Department of Gastroenterology, Yanzhou people's Hospital, 1 health Road, Shandong, Yanzhou, China Patentee before: Song Xueping |
|
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Li Peng Inventor before: Song Xueping |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170425 Address after: 414000 Yunxi Industrial Park, Yunxi District, Hunan, Yueyang Patentee after: Yueyang Pengcheng Technology Development Co., Ltd. Address before: 214400 Jiangyin Economic Development Zone, Jiangsu, Qin Shan Road, No. 8 Patentee before: Tianjiang Pharmaceutical Industry Co., Ltd., Jiangyin |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130313 Termination date: 20180110 |